Evolus
在场
高管
查看带有其 13 名主要高管的组织结构图
Evolus 搜索最多的简介
- David Moatazedi, President and Chief Executive Officer
- Brady Stewart, Director
- Vikram Malik, Director
高管在Evolus变化
- Robert Hayman, Director, 已经离开公司 (新闻发布的2024四月5号).
- Simone Blank, Director, 已经离开公司 (新闻发布的2024四月5号).
- Nareg Sagherian已作为Vice President and Head of Global Investor Relations & Corporate Communications加入公司 (新闻发布的2024一月5号).
创建提醒
跟踪 Evolus 的高管变动
生物技术
Evolus 拥有 2,282 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Evolus 的最新新闻稿
- Evolus | Evolus to Participate in Three Upcoming Investor Conferences
- Evolus | Evolus Reports Second Quarter 2020 Results and Provides Business Update
- Evolus | Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020
- Evolus | Evolus Provides Update on United States International Trade Commission (USITC) Case
- Evolus | Evolus Strengthens Balance Sheet; Secures $40 Million Investment
- Evolus | Evolus Reports First Quarter 2020 Results and Provides Business Update
- Evolus | Evolus to Report First Quarter 2020 Financial Results and Provide a Business Update on Monday, May 11, 2020
- Evolus | Evolus Provides Strategic Business Update
- Evolus Provides Update on International Trade Commission (ITC) Case | Evolus, Inc.
- Evolus to Participate in Barclays 2020 Global Healthcare Conference | Evolus, Inc.
- View more press releases Close
关于 Evolus 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 David Moatazedi 
